R&D Life sciences real estate: Beyond labs Growth in biotechnology, pharmaceutical R&D, and advanced therapies is driving demand for specialist laboratory space.
News Rapid DEA review clears way for Takeda's narcolepsy launch Takeda has started to roll out its new narcolepsy therapy in the US, with competitive pricing to Jazz Pharma's current market leader Xywav.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
